Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCLETIS-B

9.970
+0.2903.00%
Volume:8.29M
Turnover:82.85M
Market Cap:9.90B
PE:-30.40
High:10.150
Open:9.680
Low:9.680
Close:9.680
52wk High:18.750
52wk Low:1.130
Shares:993.00M
HK Float Shares:993.00M
Volume Ratio:1.03
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.328
ROE:-12.77%
ROA:-12.32%
PB:4.86
PE(LYR):-30.40
PS:3836.11

Loading ...

HK Movers | Biopharmaceutical Stocks Jump With SinoMab BioScience up 18%

Tiger Newspress
·
May 30

Ascletis Pharma's Application for Plaque Psoriasis Drug Cleared by US FDA

MT Newswires Live
·
May 22

BRIEF-Ascletis Announces U.S. FDA Clearance Of Ind Application For Its Oral Small Molecule Il-17 Inhibitor, ASC50, For The Treatment Of Psoriasis

Reuters
·
May 22

BRIEF-Ascletis Pharma Says US FDA Cleared IND Application For Oral Small Molecule IL-17 Inhibitor, ASC50

Reuters
·
May 22

Ascletis Pharma Inc. Announces FDA Clearance for Phase I Trial of ASC50, a Promising Oral IL-17 Inhibitor for Psoriasis Treatment

Reuters
·
May 22

Ascletis Pharma Inc. Conducted Annual General Meeting

Reuters
·
May 22

Ascletis Doses First Patients for US Trial of Obesity Drug Combo

MT Newswires Live
·
May 21

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
May 21

BRIEF-Ascletis Announces First Participants Dosed In A U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, And Semaglutide For The Treatment Of Obesity

Reuters
·
May 20

Ascletis Pharma Initiates U.S. Clinical Study Combining ASC47 and Semaglutide for Obesity Treatment

Reuters
·
May 20

HK Movers | HK's Biotech Shares Soar. Cstone Pharma Soars 20%; RemeGen up 10%; Ascletis up 6%

Tiger Newspress
·
May 20

HK Movers | HK's Biotech Shares Pull Back. Alphamab, Cstone Pharma, Ascletis down about 10%; Immuneonco, Laekna down over 9%

Tiger Newspress
·
May 12

Ascletis Pharma to Present Results of Preliminary Studies on Anti-Obesity Drug

MT Newswires Live
·
May 06

Ascletis Pharma's Phase 1B Trial for Obesity Tablets Showed Favorable Safety Results

MT Newswires Live
·
Apr 23

HK Movers | Biotech Stocks Rally With Zai Lab up 8%

Tiger Newspress
·
Apr 23

HK Movers|HK Pharma Stocks Shined. Ascletis up 18%; Dualitybio up 8%; Zai Lab, HBM and Remegen Up 6%.

Tiger Newspress
·
Apr 22